Benzinga – MDMA (Or Ecstasy) Improve Sexual Desire in Women? MINDCURE Launches Research Program To Find Out

MINDCURE is researching HSDD treatment for women with MDMA, a substance currently in phase 3 clinical trials for PTSD. Around 9.5 million premenopausal US women are affected by HSDD. Other market alternatives treat only physiological symptoms. The program’s research protocol involves MDMA-assisted psychotherapy, and the company’s revenue stream involves protocol-derived training programs.

Access the article here.